Microsurgical clipping as a retreatment strategy for previously ruptured aneurysms treated with the Woven EndoBridge (WEB) device: a mono-institutional case series

BACKGROUND: Since its approval by the US Food and Drug Administration (FDA) in 2018, the flow disruptor Woven EndoBridge (WEB) device has become increasingly popular for the endovascular treatment of unruptured and ruptured cerebral aneurysms. However, the occlusion rates seem rather low and the ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Kranawetter, B., Hernández, S., Mielke, D., Ernst, M.S., Malinova, V., Rohde, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319653/
https://www.ncbi.nlm.nih.gov/pubmed/37178247
http://dx.doi.org/10.1007/s00701-023-05596-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319653/
https://www.ncbi.nlm.nih.gov/pubmed/37178247
http://dx.doi.org/10.1007/s00701-023-05596-5

Ejemplares similares